BR9705473A - Vacina viva atentuada de neospora - Google Patents

Vacina viva atentuada de neospora

Info

Publication number
BR9705473A
BR9705473A BR9705473A BR9705473A BR9705473A BR 9705473 A BR9705473 A BR 9705473A BR 9705473 A BR9705473 A BR 9705473A BR 9705473 A BR9705473 A BR 9705473A BR 9705473 A BR9705473 A BR 9705473A
Authority
BR
Brazil
Prior art keywords
neospora
live vaccine
enhanced live
enhanced
vaccine
Prior art date
Application number
BR9705473A
Other languages
English (en)
Inventor
Byron L Blagburn
David A Brake
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21858396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9705473(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of BR9705473A publication Critical patent/BR9705473A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9705473A 1996-11-12 1997-11-12 Vacina viva atentuada de neospora BR9705473A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3124896P 1996-11-12 1996-11-12

Publications (1)

Publication Number Publication Date
BR9705473A true BR9705473A (pt) 1999-04-06

Family

ID=21858396

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9705473A BR9705473A (pt) 1996-11-12 1997-11-12 Vacina viva atentuada de neospora

Country Status (16)

Country Link
US (3) US6656479B2 (pt)
EP (1) EP0841392B1 (pt)
JP (2) JP3690709B2 (pt)
CN (2) CN1572322A (pt)
AR (2) AR010583A1 (pt)
AT (1) ATE271122T1 (pt)
AU (1) AU733076B2 (pt)
BR (1) BR9705473A (pt)
CA (1) CA2220588C (pt)
DE (1) DE69729839T2 (pt)
DK (1) DK0841392T3 (pt)
ES (1) ES2224210T3 (pt)
NZ (1) NZ329095A (pt)
PT (1) PT841392E (pt)
TW (1) TW557214B (pt)
ZA (1) ZA9710130B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE271122T1 (de) * 1996-11-12 2004-07-15 Pfizer Attenuierter lebender neospora impfstoff
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
ATE352315T1 (de) * 1997-10-20 2007-02-15 Bayer Corp Neospora impstoff
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) * 2000-07-28 2000-08-24 Insearch Limited Parasites
WO2003038434A2 (en) * 2001-10-31 2003-05-08 Pfizer Products Inc. Serological assay for neospora caninum
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
AU2004257939B2 (en) 2003-07-22 2008-06-05 Valneva Production of poxviruses with adherent or non adherent avian cell lines
KR20060123346A (ko) * 2003-12-19 2006-12-01 시애틀 바이오메디칼 리서치 인스티튜트 유전적으로 감독된 말라리아 생 백신
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
MX2009001477A (es) * 2006-08-09 2009-02-18 Vivalis Metodo de produccion de un aviar transgenico utilizando celulas progenitoras embrionicas.
EP1985305A1 (en) 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
EP1995309A1 (en) * 2007-05-21 2008-11-26 Vivalis Recombinant protein production in avian EBx® cells
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
FR2994193B1 (fr) * 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
US10864260B2 (en) 2015-10-28 2020-12-15 Universidad Complutense De Madrid Neospora vaccine composition
CN109789097B (zh) 2016-10-05 2021-05-18 硕腾服务有限责任公司 提供用作强效活疫苗的稳定脱水的原生动物的冻干方法
JP2021525517A (ja) 2018-05-30 2021-09-27 インスティテュート・フォー・リサーチ・イン・バイオメディシンＩｎｓｔｉｔｕｔｅ Ｆｏｒ Ｒｅｓｅａｒｃｈ Ｉｎ Ｂｉｏｍｅｄｉｃｉｎｅ 内在性活性化誘導シチジンデアミナーゼを利用することによるｂリンパ球のエンジニアリング
CN111187721A (zh) * 2020-01-17 2020-05-22 中国农业大学 grx 5基因缺失的新孢子虫弱毒虫株及其构建方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976553A (en) 1993-11-04 1999-11-02 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6716423B1 (en) * 1994-03-21 2004-04-06 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
AU7677896A (en) * 1995-11-09 1997-05-29 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
ATE271122T1 (de) * 1996-11-12 2004-07-15 Pfizer Attenuierter lebender neospora impfstoff
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
US20040062772A1 (en) 2004-04-01
US20020044952A1 (en) 2002-04-18
EP0841392A2 (en) 1998-05-13
ES2224210T3 (es) 2005-03-01
EP0841392B1 (en) 2004-07-14
CN1190127A (zh) 1998-08-12
US6994861B2 (en) 2006-02-07
MX9708701A (es) 1998-09-30
ZA9710130B (en) 1999-06-10
CN1226406C (zh) 2005-11-09
ATE271122T1 (de) 2004-07-15
TW557214B (en) 2003-10-11
US6656479B2 (en) 2003-12-02
AU733076B2 (en) 2001-05-03
JP3690709B2 (ja) 2005-08-31
DE69729839D1 (de) 2004-08-19
US20060073157A1 (en) 2006-04-06
CA2220588A1 (en) 1998-05-12
AR053286A2 (es) 2007-04-25
JP3935180B2 (ja) 2007-06-20
PT841392E (pt) 2004-11-30
JP2005230018A (ja) 2005-09-02
DK0841392T3 (da) 2004-11-22
CN1572322A (zh) 2005-02-02
DE69729839T2 (de) 2005-07-21
JPH10167983A (ja) 1998-06-23
AU4520397A (en) 1998-05-14
NZ329095A (en) 1998-03-25
AR010583A1 (es) 2000-06-28
CA2220588C (en) 2008-07-22
EP0841392A3 (en) 1999-03-24

Similar Documents

Publication Publication Date Title
BR9705473A (pt) Vacina viva atentuada de neospora
BR9711853A (pt) Vacinas
NO20003303D0 (no) Vaksine
PT921808E (pt) Formulacoes peptidicas nao aquosas polares aproticas
ID21031A (id) Kornea buatan
DE69703171D1 (de) Drehgeber
ID17860A (id) Komposisi vaksin
DE69715175D1 (de) Bilderzeugung
DE69733812D1 (de) Heizkessel
DE69730383D1 (de) Abtastsystem
DE69729607D1 (de) Bukkalrohr
DK0956042T3 (da) Mykosevaccine
BR9607462A (pt) Vacina viva em forma de gel
DE59712036D1 (de) Computertomograph
BR9701988A (pt) Extrato de auto-purgação
PT898969E (pt) Vacina de neospora
NO20005599D0 (no) Vaksine
DE69803367D1 (de) Mechanisch schrumpfbare Muffe
DE59910711D1 (de) Austastschaltung
ATA46196A (de) Feuerstätte
DE59609687D1 (de) Faltrollostange
DE59701858D1 (de) Endenschutz
KR970003368U (ko) 5구 콘센트
SE9600402L (sv) Hållaranordning
KR970063238U (ko) 소형 전기보일러

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA (ART. 8O COMBINADO COM ART. 13 DA LPI); AS REIVINDICACOES ESTAO INDEFINIDAS E/ OU NAO ESTAO FUNDAMENTADAS NO RELATORIO DESCRITIVO (ART. 25 DA LPI 9279/96); NAO E CONSIDERADO INVENCAO, UMA VEZ QUE INCIDE NO ART. 10 (IX) DA LPI 9279/96.

B12B Appeal against refusal [chapter 12.2 patent gazette]